From the Beatles to biologics – how Liverpool became a life science hotspot The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe The Guardian - UK · Jan 12, 2025
Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo. Fortune · Dec 20, 2024
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression outcomes in treated patients. Benzinga · Dec 6, 2024
Astrazeneca Appoints New China Head Amid Investigation Concerns AstraZeneca appoints Iskra Reic as new head of China operations amid investigations and challenges in the pharmaceutical industry in China. Top News · Dec 5, 2024
First new treatment for asthma and COPD in half a century – new study Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone. The Conversation · Nov 29, 2024
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines. MarketBeat · Nov 28, 2024
AstraZeneca's Truqap Demonstrates Progress in Advanced Prostate Cancer Treatment Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca's Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a statistically Benzinga · Nov 25, 2024
Breast cancer drug blocked for NHS use in England and Wales after talks collapse National Institute for Health and Care Excellence unable to reach price agreement with manufacturers of Enhertu The Guardian - UK · Nov 19, 2024
Breast cancer drug blocked for NHS use as price talks break down for third time Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name Enhertu. Evening Standard · Nov 19, 2024
Breast cancer drug blocked for NHS use as price talks break down – leaving charities ‘beyond devastated’ Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name Enhertu The Independent UK · Nov 19, 2024
Pharma shares hit as Trump picks RFK Jr to lead health department Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK The Guardian - UK · Nov 15, 2024
AstraZeneca’s numbers are good but trouble in China could drag it down Profits beat forecasts but a 17% fall in share price since executives were detained by Beijing may be hard to shake The Guardian - UK · Nov 12, 2024
AstraZeneca says it takes China investigation ‘very seriously’ UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment The Guardian - UK · Nov 12, 2024
AstraZeneca boss says firm takes China probe ‘very seriously’ The group’s shares have tumbled after it emerged that the firm’s China president has been detained as Chinese authorities deepen their investigation. Evening Standard · Nov 12, 2024
Evening Standard · Nov 12, 2024 FTSE 100 Live 12 November: Vodafone and AstraZeneca results fail to revive shares, Metro Bank fined £16m Cracks are appearing in the labour market after the unemployment rate today rose to 4.3%.
International Business Times · Nov 7, 2024 Pharma Giant AstraZeneca Says China Chief Detained Leon Wang, president of AstraZeneca China, "has been detained", a representative of the firm's global media team said in an email to AFP.
The Guardian - UK · Nov 5, 2024 AstraZeneca shares tumble after reports China unit is linked to insurance fraud Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price
Evening Standard · Nov 5, 2024 AstraZeneca drags on FTSE as Wall Street positive amid US election voting The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39.
The Guardian - UK · Nov 5, 2024 OBR moving to ‘trust but verify’ relationship with Treasury after ‘black hole’ row – as it happened Rolling coverage of the latest economic and financial news
The Guardian - UK · Oct 30, 2024 US economic growth slows, as Germany avoids recession and France gets Olympics boost – as it happened Eurozone GDP grew by 0.4% in the last quarter, faster than expected, as Germany’s economy avoids second contraction in a row
The Guardian - UK · Oct 25, 2024 AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly
The Guardian - UK · Oct 15, 2024 ‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare
The Conversation · Oct 7, 2024 One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.
Evening Standard · Sep 28, 2024 Boris Johnson considered invading Holland to seize Covid vaccines The then prime minister convened a meeting of senior military officials to discuss the plans.
The Guardian - UK · Sep 27, 2024 Boris Johnson: we considered ‘aquatic raid’ on Netherlands to seize Covid vaccine Former prime minister admits in extract from forthcoming book that he discussed possible aquatic operation at height of pandemic